Low-dose Naltrexone, Autoimmune and Lyme Disease by Nat Jones, RPh, FAPC

Low-Dose Naltrexone (LDN) therapy was developed in 1985 by Dr. Bernard Bihari, a Doctor of Internal Medicine, Psychiatry, and Neurology. Dr. Bihari changed his research interest from addiction to AIDS when the AIDS epidemic occurred and discovered that AIDS patients had 20% of the normal endorphin levels of healthy patients….learn more about Dr. Bihari’s research, LDN, and more in this course with Nat Jones.